XML 29 R14.htm IDEA: XBRL DOCUMENT
v3.23.2

Investments | 12 Months Ended
--- | ---
Jun. 30, 2023
Equity Method Investments and Joint Ventures [Abstract] |
Investments | Investments Equity investments by measurement category as of June 30, 2023 and June 30, 2022 were as follows (in thousands):
Measurement category | 2023 |  | 2022
Fair value | $ | 12,423 |  |  | $ | 9,167 |
Measurement alternative | 68,748 |  |  | 39,290 |
Equity method | 65,366 |  |  | 9,918 |
Total | $ | 146,537 |  |  | $ | 58,375 |
The following table shows a reconciliation of the changes in our equity investments for the year ended June 30, 2023 (in thousands):
| Non-marketable securities |  | Marketable securities |  | Equity method investments |  | Total
Balance at the beginning of the period | $ | 39,290 |  |  | $ | 9,167 |  |  | $ | 9,918 |  |  | $ | 58,375 |
Additions to investments (1) | 21,738 |  |  | 4,991 |  |  | 62,733 |  |  | 89,462 |
Observable price adjustments on non-marketable equity securities | 12,612 |  |  | — |  |  | — |  |  | 12,612 |
Impairment of investments | (4,892) |  |  | — |  |  | — |  |  | (4,892) |
Realized gains on marketable and non-marketable equity securities | 3,937 |  |  | — |  |  | — |  |  | 3,937 |
Proceeds from exits of investments | (3,937) |  |  | — |  |  | — |  |  | (3,937) |
Unrealized losses on marketable equity securities | — |  |  | (1,735) |  |  | — |  |  | (1,735) |
Loss attributable to equity method investments | — |  |  | — |  |  | (7,265) |  |  | (7,265) |
Dividends received | — |  |  | — |  |  | (2,873) |  |  | (2,873) |
Foreign currency translation adjustments | — |  |  | — |  |  | 2,853 |  |  | 2,853 |
Carrying value at the end of the period | $ | 68,748 |  |  | $ | 12,423 |  |  | $ | 65,366 |  |  | $ | 146,537 |
(1)Includes additions from purchases and an equity method investment acquired and measured at fair value via our acquisition of MEDIFOX DAN. Refer to Note 17 herein. The following table shows a reconciliation of the changes in our equity investments for the year ended June 30, 2022 (in thousands):
| Non-marketable securities |  | Marketable securities |  | Equity method investments |  | Total
Balance at the beginning of the period | $ | 23,002 |  |  | $ | 29,084 |  |  | $ | 17,154 |  |  | $ | 69,240 |
Net additions (reductions) to investments (2) | 11,775 |  |  | (3,202) |  |  | 1,250 |  |  | 9,823 |
Observable price adjustments on non-marketable equity securities | 5,367 |  |  | — |  |  | — |  |  | 5,367 |
Impairment of investments | (3,209) |  |  | — |  |  | — |  |  | (3,209) |
Realized gains on marketable and non-marketable equity securities | 2,355 |  |  | 1,626 |  |  | — |  |  | 3,981 |
Unrealized losses on marketable equity securities | — |  |  | (18,341) |  |  | — |  |  | (18,341) |
Loss attributable to equity method investments | — |  |  | — |  |  | (8,486) |  |  | (8,486) |
Carrying value at the end of the period | $ | 39,290 |  |  | $ | 9,167 |  |  | $ | 9,918 |  |  | $ | 58,375 |
(2)Net additions (reductions) to investments includes additions from purchases, reductions due to exits of securities, or reclassifications due to our acquisition of an investee in which we held a prior equity interest. Net unrealized gains and losses recognized in the years ended June 30, 2023, 2022 and 2021 for equity investments in non-marketable and marketable securities still held as of those respective dates were a gain of $6.0 million, a loss of $16.2 million, and a gain of $14.5 million, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//320/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Topic 321 -Publisher FASB -URI https://asc.fasb.org//321/tableOfContent Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Topic 325 -Publisher FASB -URI https://asc.fasb.org//325/tableOfContent + Details
Name: | us-gaap_InvestmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration